Skip to main content

Table 1 Clinicopathological characteristics of all the participants

From: Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer

 

Lung cancer group (N = 157)

Healthy group (N = 189)

P value

Age, average (min, max)

62.3(37,80)

54.8(22,80)

 < 0.0001

Gender, n (%)

  

 < 0.0001

Male

106(67.5%)

55(29.1%)

 

Female

51(32.5%)

118(62.4%)

 

NA

0

16(8.5%)

 

TNM, n (%)

 

/

 

I

3(1.91%)

  

II

9(5.73%)

  

III

49(31.21%)

  

IV

82(52.23%)

  

NA

14(8.92%)

  

Histology

   

LUAD

62(39.49%)

  

LUSC

48(30.57%)

  

SCLC

25(15.92%)

  

Others

22(14.01%)

  
  1. Clinicopathological characteristics of all the participants